Sign Up Today

therapies & services > GAMMAGARD S/D

Available January 2, 2008 for your patients who require a Low IgA IVIG therapy, Baxter offers GAMMAGARD S/D with IgA less than 1 µg/mL in a 5% solution.

GAMMAGARD SD with IgA less than 1 µg/mL in a 5% solution must not be used in patients with selective IgA efficiency where the deficiency is the only abnormality of concern.

• Available in both 5g and 10g sizes
• Unique product codes to simplify ordering
• IgA less than 1 µg/mL in a 5% solution
• No clinical studies have been specifically conducted using only lots whose IgA content was less than 1 µg/mL.
• IVIG preparations depleted of IgA (0.4 to 2.9 µg/mL) were shown to be better tolerated by a limited number of patients who reacted to IVIG preparations with higher IgA concentrations. However, the concentration of IgA that will not provoke a reaction is not known, and therefore all IVIG preparations carry the risk of inducing an anaphylactic reaction to IgA.

Baxter is committed to the primary immune deficient (PI) patient community. To ensure that your IgA sensitive patients continue to receive GAMMAGARD S/D, you may register your patients by completing the IgA sensitive participant profile form and submitting it for evaluation by the Baxter Professional Services Group. The form includes instructions for completing the patient profile and a Q&A section on registering patients and ordering GAMMAGARD S/D with IgA less than 1 µg/mL in a 5% solution.

 

Available Sizes:

Product Code	NDC Number	Volume	Grams
1501374	0944-2655-03	96mL	5g
1501375	0944-2655-04	192mL	10g

 

Please see the Important Safety Information and Full Prescribing Information for GAMMAGARD S/D [Immune Globulin Intravenous (Human)], IgA less than 1 µg/mL in a 5% solution.

To view PDFs, you will need Adobe® Acrobat® Reader® software.